213 related articles for article (PubMed ID: 19178532)
1. The effects of metformin on endogenous androgens and SHBG in women: a systematic review and meta-analysis.
Barba M; Schünemann HJ; Sperati F; Akl EA; Musicco F; Guyatt G; Muti P
Clin Endocrinol (Oxf); 2009 May; 70(5):661-70. PubMed ID: 19178532
[TBL] [Abstract][Full Text] [Related]
2. Effects of placebo-controlled insulin-sensitizing drugs on hormonal parameters in polycystic ovary syndrome patients: A network meta-analysis.
Huang R; Zhao PF; Xu JH; Liu DD; Luo FD; Dai YH
J Cell Biochem; 2018 Mar; 119(3):2501-2511. PubMed ID: 28941255
[TBL] [Abstract][Full Text] [Related]
3. Effect of atorvastatin on testosterone levels.
Shawish MI; Bagheri B; Musini VM; Adams SP; Wright JM
Cochrane Database Syst Rev; 2021 Jan; 1(1):CD013211. PubMed ID: 33482034
[TBL] [Abstract][Full Text] [Related]
4. Impact of pharmacological interventions on biochemical hyperandrogenemia in women with polycystic ovary syndrome: a systematic review and meta-analysis of randomised controlled trials.
Abdalla MA; Shah N; Deshmukh H; Sahebkar A; Östlundh L; Al-Rifai RH; Atkin SL; Sathyapalan T
Arch Gynecol Obstet; 2023 May; 307(5):1347-1376. PubMed ID: 35434762
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of anti-androgens in the management of polycystic ovary syndrome: a systematic review and meta-analysis of randomised controlled trials.
Alesi S; Forslund M; Melin J; Romualdi D; Peña A; Tay CT; Witchel SF; Teede H; Mousa A
EClinicalMedicine; 2023 Sep; 63():102162. PubMed ID: 37583655
[TBL] [Abstract][Full Text] [Related]
6. Insulin Sensitizers for Improving the Endocrine and Metabolic Profile in Overweight Women With PCOS.
Xing C; Li C; He B
J Clin Endocrinol Metab; 2020 Sep; 105(9):2950-63. PubMed ID: 32490533
[TBL] [Abstract][Full Text] [Related]
7. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.
Pasquali R; Gambineri A; Biscotti D; Vicennati V; Gagliardi L; Colitta D; Fiorini S; Cognigni GE; Filicori M; Morselli-Labate AM
J Clin Endocrinol Metab; 2000 Aug; 85(8):2767-74. PubMed ID: 10946879
[TBL] [Abstract][Full Text] [Related]
8. A systematic review of GLP-1 agonists on the metabolic syndrome in women with polycystic ovaries.
Niafar M; Pourafkari L; Porhomayon J; Nader N
Arch Gynecol Obstet; 2016 Mar; 293(3):509-15. PubMed ID: 26660657
[TBL] [Abstract][Full Text] [Related]
9. Metformin and Combined Oral Contraceptive Pills in the Management of Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis.
Melin J; Forslund M; Alesi S; Piltonen T; Romualdi D; Spritzer PM; Tay CT; Pena A; Witchel SF; Mousa A; Teede H
J Clin Endocrinol Metab; 2024 Jan; 109(2):e817-e836. PubMed ID: 37554096
[TBL] [Abstract][Full Text] [Related]
10. The effect of combined oral contraception on testosterone levels in healthy women: a systematic review and meta-analysis.
Zimmerman Y; Eijkemans MJ; Coelingh Bennink HJ; Blankenstein MA; Fauser BC
Hum Reprod Update; 2014; 20(1):76-105. PubMed ID: 24082040
[TBL] [Abstract][Full Text] [Related]
11. The effect of probiotics, prebiotics, and synbiotics on hormonal and inflammatory indices in women with polycystic ovary syndrome: a systematic review and meta-analysis.
Shamasbi SG; Ghanbari-Homayi S; Mirghafourvand M
Eur J Nutr; 2020 Mar; 59(2):433-450. PubMed ID: 31256251
[TBL] [Abstract][Full Text] [Related]
12. Effects of diet and metformin administration on sex hormone-binding globulin, androgens, and insulin in hirsute and obese women.
Crave JC; Fimbel S; Lejeune H; Cugnardey N; Déchaud H; Pugeat M
J Clin Endocrinol Metab; 1995 Jul; 80(7):2057-62. PubMed ID: 7608255
[TBL] [Abstract][Full Text] [Related]
13. A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome.
Nestler JE; Powers LP; Matt DW; Steingold KA; Plymate SR; Rittmaster RS; Clore JN; Blackard WG
J Clin Endocrinol Metab; 1991 Jan; 72(1):83-9. PubMed ID: 1898744
[TBL] [Abstract][Full Text] [Related]
14. The Effect of n-3 Polyunsaturated Fatty Acid Supplementation on Androgen Status in Patients with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis of Clinical Trials.
Hajishafiee M; Askari G; Iranj B; Ghiasvand R; Bellissimo N; Totosy de Zepetnek J; Salehi-Abargouei A
Horm Metab Res; 2016 May; 48(5):281-9. PubMed ID: 27077458
[TBL] [Abstract][Full Text] [Related]
15. Endogenous Androgens and Sex Hormone-Binding Globulin in Women and Risk of Metabolic Syndrome and Type 2 Diabetes.
Fenske B; Kische H; Gross S; Wallaschofski H; Völzke H; Dörr M; Nauck M; Keevil BG; Brabant G; Haring R
J Clin Endocrinol Metab; 2015 Dec; 100(12):4595-603. PubMed ID: 26445113
[TBL] [Abstract][Full Text] [Related]
16. The effect of combination therapy with metformin and combined oral contraceptives (COC) versus COC alone on insulin sensitivity, hyperandrogenaemia, SHBG and lipids in PCOS patients.
Cibula D; Fanta M; Vrbikova J; Stanicka S; Dvorakova K; Hill M; Skrha J; Zivny J; Skrenkova J
Hum Reprod; 2005 Jan; 20(1):180-4. PubMed ID: 15576394
[TBL] [Abstract][Full Text] [Related]
17. The effects of metformin on metabolic and cardiovascular risk factors in nonobese women with polycystic ovary syndrome.
Sahin Y; Unluhizarci K; Yilmazsoy A; Yikilmaz A; Aygen E; Kelestimur F
Clin Endocrinol (Oxf); 2007 Dec; 67(6):904-8. PubMed ID: 17666089
[TBL] [Abstract][Full Text] [Related]
18. The effects of metformin and diet on plasma testosterone and leptin levels in obese men.
Ozata M; Oktenli C; Bingol N; Ozdemir IC
Obes Res; 2001 Nov; 9(11):662-7. PubMed ID: 11707532
[TBL] [Abstract][Full Text] [Related]
19. [Endocrine and metabolic effects of metformin in combination with compound cyproterone acetate in women with polycystic ovarian syndrome].
Ye BL; Yang HY; Zhao JZ; Lin JJ; Lin WQ
Zhonghua Fu Chan Ke Za Zhi; 2003 Dec; 38(12):745-8. PubMed ID: 14728846
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
